Interestingly, patients with grade IV glioma, wild-type IDH, no co-deletion of 1p/19q, and older (>41 years) had a high-risk score in all three datasets, indicating that a high-risk score was likely to predict malignancy (Figure 3C; Supplementary Figures S3C–H). The gene discussed is IDH1; the disease is central nervous system cancer.